Navigation Links
Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease
Date:5/15/2009

Cimzia(R) (certolizumab pegol) now offered in an innovative prefilled syringe designed in partnership with OXO GOOD GRIPS(R)

ATLANTA, May 15 /PRNewswire/ --- UCB today announced that Cimzia(R) (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor) approved in the U.S. for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy, is now available for self-administration in a prefilled syringe designed in partnership with OXO GOOD GRIPS(R) a company dedicated to providing innovative consumer products that make everyday life easier.

"We looked at a variety of unmet needs for Crohn's disease patients and found that many prefer a prefilled syringe when taking biologic medications," said David Robinson, vice president and general manager of UCB's Immunology Business Unit. "This newly designed, easy-to-use syringe, developed with a renowned consumer products company like OXO(R), will enable many patients to conveniently self-administer their therapy every four weeks."

The Cimzia(R) prefilled syringe, designed by UCB in partnership with OXO GOOD GRIPS(R) is available exclusively for use with Cimzia(R). The companies recognized the importance of designing a syringe and packaging components with the patient in mind to provide ease of use, comfort, control and confidence.

The new syringe provides a soft, non-slip grip on the flange which allows the patients to hold the syringe steady using various grip positions so it is easy and comfortable to use. The large and soft thumb pad on the plunger makes it easy to push for patients. The rounded finger loop allows for easy removal of the needle cover. The easy-to-read syringe barrel helps to ensure patients receive the entire dose as they can see the medicine ins
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
2. UCBs CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
3. Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohns Patients
4. UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
5. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
6. New Online Project Management Fundamentals for Healthcare Module Available
7. KT Tape: Secret Weapon of Elite Athletes - Now Available to Everyone
8. Fiber Technology Products that Help Combat Spread of Superbugs Now Available to the Consumer Market
9. Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available
10. New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
11. Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)... lift spirits, recognize signs of depression , ... many seniors, the holiday season can trigger mela...le with health issues or worry about money problem..., To help overcome the seasonal blues, the AGS F... advice: , Get out and socialize or invite famil...
(Date:11/27/2009)...v. 27 /PRNewswire/ - Uploadable USB pedometers may...wellness. A combination of advanced accelerometer ...g a long term concern over the accuracy of self-re... and reward improved participation in a fitness pr... first wellness suppliers to integrate this techno...
(Date:11/27/2009)...7 Considered a highly r...ears ago, solid organ transplantation is now a lif...rdinary men and women who gathered at the Winspear...gether from medical centers around the world to ce...ansplant Institute (BRTI), one of the pioneers of ...
(Date:11/27/2009)...., Nov. 27 Preventing d...nd fortunately every year, new vaccines are being ...vaccines boost immunity for the same period of tim..., needed to keep immunity strong? ,, In this ...erican Academy of Pediatrics, Michael Pichichero M...
(Date:11/27/2009)... Israel, Nov. 27 Shamir ...), a leading provider of innovative products and t... today that its board of directors had declared a ...$ 10 million (approximately NIS 37.62 million base...exchange), or approximately US$ 0.609 (approximate...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3
...ke, , , WEDNESDAY, Dec. 24 (HealthDay New...ich can be a particular concern for people managin...ociate chairwoman for integrated medicine and psyc...ffered in a news release from the university, incl...
...enver (DU) Associate Professor Rene Botta suggests...ate students to wash their hands more frequently a...7, researchers posted messages in the bathrooms of... vivid graphics and photos. The messages resulted ...
...asier time quitting may have the benefit of specif...ew study by a team of federal scientists at the Na... Manhasset, NY (Vocus) December 23, 2008 -...al scientists at the National Institute on Drug Ab...
... treating gum disease in patients who have diabete...l scaling is linked to 10 to 12 percent lower medi...ing but the study was not designed to firmly estab... U-M School of Public Health. Taylor led the resea...
...man Services recently awarded Jefferson Hospital f...ving a lifesaving organ donation conversion rate o...eriod. The award was given during the fourth Nati...k tirelessly to ensure their patients are receivin...
... inflammation in perihepatic capsules with concomi...per abdomen appeared as the main symptom. These ca...ases for which the major symptom is pain in the ri... by antibiotic therapy. Nevertheless, without suff...
Other Medicine News:Health News:University of Denver uses 'gross' messaging to increases handwashing, fight Norovirus 2Health News:Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine 2Health News:Treating gum disease linked to lower medical costs for patients with diabetes 2Health News:Jefferson Hospital for Neuroscience receives Department of Health and Human Services award 2Health News:What is the clinical character of Fitz-Hugh-Curtis syndrome? 2
(Date:11/25/2009)...Newswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: ...mmitted to discovering, developing and commerciali...ed financial results for the fiscal year ended Sep...held $58.4 million in cash, cash equivalents and s... 2009 Highlights ,, RG7128 ,, Phase 2b ...
(Date:11/25/2009)...ire/ -- BioTrends Research Group, Inc. released Wa...rt, the first in a multi-phase syndicated market r...tho-Biotech,s Stelara, from product launch through...of the report provides quantitative information fr...ation from a subset of 20. The reports assess tri...
(Date:11/25/2009)... Remedium Technologies I...m that stops severe bleeding, won first prize and ...ry of the Global Security Challenge 2009, company ... than 100 entries from around the world, Remedium,... Summit conference held at the London School of Bu...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Walmart Foundation Commits 24500 000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 51211 1Walmart Foundation Commits 24500 000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 51211 2Walmart Foundation Commits 24500 000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 51211 3Conning Research 3A Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 51207 1Conning Research 3A Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 51207 2Motion analysis helps soccer players get their kicks 51204 1Motion analysis helps soccer players get their kicks 51204 2Motion analysis helps soccer players get their kicks 51204 3
...OLULU, Jan. 28 Results of a pre-clinical study of...ker, shows it has the,potential to be safe, select...,for pain relief. It also holds promise in multip...ansdermal patch, and pills. Data were presented,t...th Annual Meeting. , In the study, leconotide,...
...OLULU, Jan. 28 Today at the American Academy of P...om University of California at,San Diego report ...ring an,epidural steroid injection for back pain. ...ch steroids were given, the amount of steroid used...with the steroid. , Epidural steroid injection...
Other Medicine Technology:Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment 2Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment 3Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain 2
Siemens Webcast
Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,Flexilog sing...
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,A range of fo...
Medicine Products: